论文部分内容阅读
To further explore the potential of DCK analogs as anti-HIV drug candidates, ten new tri-substituted (3R,4R)-3,4-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) derivatives (4-13)were designed, synthesized, and evaluated against HIV replication in MT4 cells and H9 lymphocytes.